MarketAxess Holdings Inc. MKTX
Composite 58/100; the shares have moved about 50% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 38/100 — a moderate mark against it.
Balance-sheet strength ranks 72/100 — a moderate point in its favour. Quality ranks 70/100 — a moderate point in its favour. Income ranks 64/100 — a moderate point in its favour.
Growth ranks 38/100 — a moderate mark against it. Valuation ranks 50/100 — a slight mark against it. Momentum ranks 50/100 — a slight mark against it.
What the company does MarketAxess operates an electronic trading platform for institutional investors and broker-dealers in fixed-income securities, including corporate bonds, emerging market debt, and government bonds. Its Open Trading protocols and data offerings (e.g., CP+, Axess All) facilitate all-to-all anonymous trading and analytics.
Key financials MKTX reports strong profitability with ROE 24.3%, ROA 10.8%, and ROCE 16.9%. Margins are robust: gross 62.1%, operating 43.9%, net 35.5%. Revenue grew 11.9% while EPS surged 450.0%. The balance sheet is healthy (debt/equity 0.24, current ratio 4.94).
Stock health Quality and income scores are high (76.6 and 81.2), but momentum is weak (momentum score 30.5). RSI(14) is elevated at 85.50, and the stock is -21.41% below its 52-week high.
Price vs fair value The stock trades at a **PREMIUM of 7.59%** versus the 12-month analyst target of 150.40. - NYSE parent Intercontinental Exchange agreed to buy MKTX for $6B, citing the rise of bond e-trading (The Wall Street Journal, MT Newswires). - Insider Monkey highlighted a 33% premium in the merger deal (Insider Monkey). - Analyst upgrades/downgrades in unrelated names may have driven sector rotation into financials (The Fly, MT Newswires).
Looking forward Forward P/E is 14.45, below the trailing 13.83, suggesting modest earnings growth expectations. High margins and strong ROE support valuation, but momentum remains a concern.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.